Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.
作者： John S. Bomalaski , Mike A. Clark
DOI: 10.1007/S11926-004-0075-3
关键词: Hyperuricemia 、 Allopurinol 、 Pharmacology 、 Urate oxidase 、 Gout 、 Febuxostat 、 Xanthine oxidase 、 Uric acid 、 Fenofibrate 、 Medicine
摘要: … Benziodarone and allopurinol have been shown to be effective in controlling hyperuricemia in renal transplant patients, and benziodarone at greater than 75 mg per day is statistically …
springer.com
sci-hub.se 参考文章(71)
Somchai Akkasilpa, Utis Deesomchok, Punchong Hanvivadhanakul, Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients. Journal of the Medical Association of Thailand Chotmaihet thangphaet. ,(2002)
Robert A. Terkeltaub, Gout New England Journal of Medicine. ,vol. 349, pp. 1647- 1655 ,(2003) , 10.1056/NEJMCP030733
L. Annemans, K. Moeremans, M. Lamotte, J. Garcia Conde, H. van den Berg, H. Myint, R. Pieters, A. Uyttebroeck, Pan-European multicentre economic evaluation of recombinant urate oxidase (rasburicase) in prevention and treatment of hyperuricaemia and tumour lysis syndrome in haematological cancer patients. Supportive Care in Cancer. ,vol. 11, pp. 249- 257 ,(2003) , 10.1007/S00520-002-0435-3
Frederick W Holtsberg, C Mark Ensor, Mike A Clark, John S Bomalaski, Uricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studies. The Journal of Rheumatology. ,vol. 29, pp. 1942- 1949 ,(2002)
W Michael O'Fallon, Sherine E Gabriel, Cynthia S Crowson, Clement J Michet, Emvalee Arromdee, Epidemiology of gout: is the incidence rising? The Journal of Rheumatology. ,vol. 29, pp. 2403- 2406 ,(2002)
Mark T. Holdsworth, Phuongthao Nguyen, Role of i.v. allopurinol and rasburicase in tumor lysis syndrome. American Journal of Health-system Pharmacy. ,vol. 60, pp. 2213- 2222 ,(2003) , 10.1093/AJHP/60.21.2213
Ching-Hon Pui, Rasburicase: a potent uricolytic agent Expert Opinion on Pharmacotherapy. ,vol. 3, pp. 433- 442 ,(2002) , 10.1517/14656566.3.4.433
Seigo Ishibuchi, Hiroshi Morimoto, Takanori Oe, Tsuguo Ikebe, Hiroyoshi Inoue, Atsushi Fukunari, Miho Kamezawa, Ichimaro Yamada, Yoichi Naka, Synthesis and structure–activity relationships of 1-Phenylpyrazoles as xanthine oxidase inhibitors Bioorganic & Medicinal Chemistry Letters. ,vol. 11, pp. 879- 882 ,(2001) , 10.1016/S0960-894X(01)00093-2
Ching-Hon Pui, Urate oxidase in the prophylaxis or treatment of hyperuricemia: the United States experience. Seminars in Hematology. ,vol. 38, pp. 13- 21 ,(2001) , 10.1016/S0037-1963(01)90039-3
J.M Moreno, V Cuervas-Mons, E Rubio, F Pons, A Herreros de T, V.S Turrión, I Millán, Chronic renal dysfunction after liver transplantation in adult patients: prevalence, risk factors, and impact on mortality. Congress of the Catalan Transplantation Society. ,vol. 35, pp. 1907- 1908 ,(2003) , 10.1016/S0041-1345(03)00642-0